Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2005 4
2006 2
2008 5
2009 5
2010 4
2011 2
2012 3
2013 7
2014 9
2015 7
2016 13
2017 14
2018 10
2019 13
2020 7
2021 18
2022 21
2023 20
2024 18
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
Hettmer S, Linardic CM, Kelsey A, Rudzinski ER, Vokuhl C, Selfe J, Ruhen O, Shern JF, Khan J, Kovach AR, Lupo PJ, Gatz SA, Schäfer BW, Volchenboum S, Minard-Colin V, Koscielniak E, Hawkins DS, Bisogno G, Sparber-Sauer M, Venkatramani R, Merks JHM, Shipley J. Hettmer S, et al. Among authors: merks jhm. Eur J Cancer. 2022 Sep;172:367-386. doi: 10.1016/j.ejca.2022.05.036. Epub 2022 Jul 12. Eur J Cancer. 2022. PMID: 35839732 Free article. Review.
Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial.
Defachelles AS, Bogart E, Casanova M, Merks JHM, Bisogno G, Calareso G, Gallego Melcon S, Gatz SA, Le Deley MC, McHugh K, Probst A, Rocourt N, van Rijn RR, Wheatley K, Minard-Colin V, Chisholm JC. Defachelles AS, et al. Among authors: merks jhm. J Clin Oncol. 2021 Sep 20;39(27):2979-2990. doi: 10.1200/JCO.21.00124. Epub 2021 Aug 3. J Clin Oncol. 2021. PMID: 34343032 Clinical Trial.
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Chisholm J, Mandeville H, Adams M, Minard-Collin V, Rogers T, Kelsey A, Shipley J, van Rijn RR, de Vries I, van Ewijk R, de Keizer B, Gatz SA, Casanova M, Hjalgrim LL, Firth C, Wheatley K, Kearns P, Liu W, Kirkham A, Rees H, Bisogno G, Wasti A, Wakeling S, Heenen D, Tweddle DA, Merks JHM, Jenney M. Chisholm J, et al. Among authors: merks jhm. Cancers (Basel). 2024 Feb 29;16(5):998. doi: 10.3390/cancers16050998. Cancers (Basel). 2024. PMID: 38473359 Free PMC article.
Maintenance Chemotherapy for Patients with Rhabdomyosarcoma.
Bisogno G, Minard-Colin V, Jenney M, Ferrari A, Chisholm J, Di Carlo D, Hjalgrim LL, Orbach D, Merks JHM, Casanova M. Bisogno G, et al. Among authors: merks jhm. Cancers (Basel). 2023 Aug 7;15(15):4012. doi: 10.3390/cancers15154012. Cancers (Basel). 2023. PMID: 37568826 Free PMC article. Review.
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial.
Bisogno G, Chisholm J, Hladun R, De Salvo GL, Guerin F, Casanova M, Mandeville H, Alaggio R, Coppadoro B, Orbach D, Ferrari A, van Rijn R, Defachelles AS, Ben-Arush M, Glosli H, Cesen M, Merks JHM, Minard-Colin V. Bisogno G, et al. Among authors: merks jhm. J Clin Oncol. 2025 Jun;43(16):1856-1862. doi: 10.1200/JCO-24-02850. Epub 2025 Mar 7. J Clin Oncol. 2025. PMID: 40053891 Clinical Trial.
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition.
Ringnalda FCAS, van Son GJF, Verweij LHG, Kim SY, Amo-Addae V, Flucke UE, Hiemcke-Jiwa LS, Langenberg KPS, Bramer JAM, Heimans L, van de Sande MAJ, van Houdt WJ, van Noesel MM, Kerstens HHD, Santoso M, Seifert G, Delattre O, Scotlandi K, Geoerger B, Merks JHM, Molenaar JJ, van Boxtel R, van de Wetering M, Sanders K, Clevers H. Ringnalda FCAS, et al. Among authors: merks jhm. Nat Commun. 2025 Aug 21;16(1):7689. doi: 10.1038/s41467-025-62673-2. Nat Commun. 2025. PMID: 40841360 Free PMC article.
Extra-osseous Ewing sarcoma.
van den Berg H, Heinen RC, van der Pal HJ, Merks JH. van den Berg H, et al. Pediatr Hematol Oncol. 2009 Jun;26(4):175-85. doi: 10.1080/08880010902855581. Pediatr Hematol Oncol. 2009. PMID: 19437320
Reply to H. B et al.
Defachelles AS, Bogart E, Casanova M, Merks JHM, Bisogno G, Calareso G, Melcon SG, Gatz SA, Le Deley MC, McHugh K, Probst A, Rocourt N, van Rijn RR, Minard-Colin V, Chisholm JC. Defachelles AS, et al. Among authors: merks jhm. J Clin Oncol. 2022 Mar 20;40(9):1030-1032. doi: 10.1200/JCO.21.02612. Epub 2022 Feb 7. J Clin Oncol. 2022. PMID: 35130027 No abstract available.
Imaging in rhabdomyosarcoma: a patient journey.
de Vries ISA, van Ewijk R, Adriaansen LME, Bohte AE, Braat AJAT, Fajardo RD, Hiemcke-Jiwa LS, Hol MLF, Ter Horst SAJ, de Keizer B, Knops RRG, Meister MT, Schoot RA, Smeele LE, van Scheltinga ST, Vaarwerk B, Merks JHM, van Rijn RR. de Vries ISA, et al. Among authors: merks jhm. Pediatr Radiol. 2023 Apr;53(4):788-812. doi: 10.1007/s00247-023-05596-8. Epub 2023 Feb 27. Pediatr Radiol. 2023. PMID: 36843091 Free PMC article.
177 results